Foot Orthoses in Patellofemoral Pain Syndrome: a Prospective Randomized Study of Morpho-specific Versus Placebo Orthoses

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT02250144
Collaborator
(none)
80
3
2
14
26.7
1.9

Study Details

Study Description

Brief Summary

Patellofemoral pain syndrome is one of the most common musculoskeletal disorders. It is defined as an anterior knee pain. Its origin is a conflict during patellar tracking, due to patellofemoral malalignment and soft tissue overload.

A few recent studies seem to show a benefit of prefabricated feet orthoses in patellofemoral pain syndrome, alone or in association with rehabilitation. However, no one has analyzed the outcome of morpho-specific foot orthoses in a prospective randomized study.

The purpose of this prospective randomized study is to compare clinical outcomes in daily living and in sports activities, between morpho-specific and placebo foot orthoses.

Morpho-specific foot orthoses are designed according to the patient's morphotype. They are intended to correct structural defects of the hindfoot, midfoot and forefoot, in the aim to correct abnormal overload during patellofemoral tracking.

Condition or Disease Intervention/Treatment Phase
  • Device: Foot orthoses
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Foot Orthoses in Patellofemoral Pain Syndrome: a Prospective Randomized Study of Morpho-specific Versus Placebo Orthoses
Study Start Date :
Jun 1, 2015
Anticipated Primary Completion Date :
Aug 1, 2016
Anticipated Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Morpho-specific foot orthoses

Morpho-specific thermo-molded foot orthoses are designed according to the patient's morphotype. Orthoses are custom-molded from different materials such as BIOFLUX resin, Covercuir MF, EVA300/60, EVA400/70, PE255/55, ABSORB Dur and CAPITON PU.

Device: Foot orthoses

Placebo Comparator: Placebo foot orthoses

The placebo foot orthoses will be made with the same principle of molding and with the same materials as for the experimental group. The only difference is that they involve no active corrective insert element : they will be made without morphotype correction.

Device: Foot orthoses

Outcome Measures

Primary Outcome Measures

  1. Item Pain of the KOOS Score [Twice : at inclusion and at 10 weeks follow-up with feet orthoses]

Secondary Outcome Measures

  1. KOOS Score (items Symptoms, Activities of daily living, Sport and recreation function, Knee-related quality of life) [Twice : at inclusion and at 10 weeks follow-up with feet orthoses]

  2. Kujala Score [Twice : at inclusion and at 10 weeks follow-up with feet orthoses]

  3. Pain level [Twice : at inclusion and at 10 weeks follow-up with feet orthoses]

    Visual Analog Scale (VAS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female aged 12-40 years

  • Patellofemoral pain syndrome

  • Patient affiliated to a social protection regime

  • Patient who signed an informed consent

  • For teenagers with no complete growth and muscular maturation, failure of appropriate rehabilitation during minimum 2 months

  • Patient informed of the results of the prior medical examination

  • Normality (no sign of osteoarthritis) of the knee radiographs

  • Ability to read and understand French

Exclusion Criteria:
  • Knee osteoarthritis

  • Systemic disease

  • Inflammatory rheumatism disease

  • Unstable knee

  • Prior patellofemoral dislocation

  • Osteochondrosis

  • Referred pain from a hip or spine disease (particularly proximal femoral epiphysiolysis in the teenagers)

  • A history of patellar trauma

  • A history of knee surgery

  • Meniscus, ligament or osteochondral pathology

  • Knee tendinitis or bursitis

  • Neurologic disease

  • Pregnancy

  • Antidepressant therapy or behavioral disorder

  • Patient unable to comply the required maximum observance

  • Impossibility to give enlightened information to the patient

  • Patient under guardianship

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cabinet libéral - 12, rue du Puits Haguenau France 67500
2 Service de Chirurgie Orthopédique - Hôpital CCOM - Hôpitaux Universitaires de Strasbourg Illkirch Graffenstaden France 67400
3 Cabinet libéral - 50, avenue des Vosges Strasbourg France 67000

Sponsors and Collaborators

  • University Hospital, Strasbourg, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT02250144
Other Study ID Numbers:
  • 5832
First Posted:
Sep 26, 2014
Last Update Posted:
Aug 7, 2015
Last Verified:
Aug 1, 2015
Keywords provided by University Hospital, Strasbourg, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2015